Mkt Cap $745M
52-Week Range
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery.
Revenue is primarily driven by Regenerative Skin And Wound (44.8%) and Instruments (26.3%).
Most recently: of this Current Report on Form 8-K (including the Press Release and selected historical financial information) shall not be incorporated by reference into any r (2026-02-26).
$745M
Market Cap
$1.7B
Revenue
-$524M
Net Income
Revenue by Segment
Revenue by Geography